Author： Raskin Philip Mohan Alok
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.15, Iss.2, 2010-06, pp. : 225-236
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Vaccine Therapies for the Prevention of Type 1 Diabetes Mellitus
By Petrovsky N. Silva D. Schatz D.A.
Pediatric Drugs, Vol. 5, Iss. 9, 2003-01 ,pp. :
Access to resources
Recommend
Prospects for the Prevention and Reversal of Type 1 Diabetes Mellitus
By Petrovsky N.
Drugs, Vol. 62, Iss. 18, 2002-01 ,pp. :
Type 1 diabetes prevention trials: the debate rages on
Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. :
A Simulation Model for Estimating Direct Costs of Type 1 Diabetes Prevention
By Hahl J.
PharmacoEconomics, Vol. 21, Iss. 5, 2003-01 ,pp. :